Ontology highlight
ABSTRACT:
INSTRUMENT(S): 6220 Time-of-Flight LC/MS
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Cell Culture
DISEASE(S): Acute Leukemia
SUBMITTER: Ye Geni
LAB HEAD: Geni Ye
PROVIDER: PXD044225 | Pride | 2023-10-24
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
P202111105148_BEA_1_Slot2-75_1_3945.d.zip | Other | |||
P202111105148_BEA_2_Slot2-76_1_3946.d.zip | Other | |||
P202111105148_CTL_1_Slot2-73_1_3943.d.zip | Other | |||
P202111105148_CTL_2_Slot2-74_1_3944.d.zip | Other | |||
txt.rar | Other |
Items per page: 5 1 - 5 of 5 |
Ye Geni G Jiao Yubo Y Deng Lijuan L Cheng Minjing M Wang Sheng S Zhang Junqiu J Ouyang Jie J Li Yong Y He Yuxin Y Tu Zhengchao Z Wang Zhen Z Song Xiaojuan X Wang Chenran C Qi Qi Q Zhang Dongmei D Wang Lei L Huang Maohua M Ye Wencai W Chen Minfeng M
International journal of biological sciences 20230821 14
Osteosarcoma (OS) patients, particularly those with distant metastasis, experience rapid progression and derive poor survival benefits from traditional therapies. Currently, effective drugs for treating patients with metastatic OS remain scarce. Here, we found that the cyclic hexadepsipeptide beauvericin (BEA) functioned as a new selective TGFBR2 inhibitor with potent antiproliferative and antimetastatic activities against OS cells<i>.</i> Functionally, BEA inhibited TGF-β signaling-mediated pro ...[more]